Product Code: ETC044947 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Singapore chemotherapy market is expected to grow at a CAGR of 6.7% during the forecast period 2020-2026. The rising prevalence of cancer, increasing investments in healthcare infrastructure and technological advances are the major drivers for the growth of this market. Furthermore, government initiatives such as free screening programs and subsidies on drugs are further driving the growth of this market in Singapore.
Increasing Prevalence Of Cancer: According to World Health Organization (WHO), nearly 819, 000 new cases were diagnosed with cancer in 2018 alone in Southeast Asia region which includes Singapore. This increasing number has created demand for chemotherapy treatments which is one of the key factors propelling growth of this market.Investments In Healthcare Infrastructure And Technological Advancement: Increasing investments from public and private entities on healthcare infrastructure & technological advancements have led to high adoption rates for various advanced chemotherapeutic agents such as targeted therapy which can be used effectively against certain types of cancers thereby leading to an increase in its demand globally including Singapore.
High Cost Of Treatment: Chemotherapy treatment requires expensive drugs that can cost up to thousands or millions USD depending upon type & severity of disease; hence it often shows financial burden on patients leading ultimately profit margins being reduced due to price competition among pharmaceutical companies & distributors thus hampering growth potentials for players operating within this market space adversely over time frame considered herewith.
Some Key Players Operating Within This Market Include Merck KGaA, Pfizer Inc., Novartis AG, Bristol Myers Squibb Company, Johnson & Johnson Services Inc., Eli Lilly And Company Among Others.
Due To Covid-19 Pandemic Outbreak Globally Including Singapore Few Hospitals Are Postponing Non Emergency Treatments Such As Chemotherapies For Certain Period Creating Shortage Of Drugs In Market Thus Affecting Revenue Generation From Sales Of Chemo Drugs During Forecast Period Herein Considered By Analysts Working On Study Undertaken For Estimation Purpose Adversely Herein With Respect To Time Frame Considered Herewith With Respect To Global Scenario At Large But It Is Expected That Its Effects Will Fade Away Over Next Few Years Allowing Revenues Generation Opportunities Again For Companies Operating Within Industry Space.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Chemotherapy Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Chemotherapy Market Revenues & Volume, 2020 & 2030F |
3.3 Singapore Chemotherapy Market - Industry Life Cycle |
3.4 Singapore Chemotherapy Market - Porter's Five Forces |
3.5 Singapore Chemotherapy Market Revenues & Volume Share, By Drug Class, 2020 & 2030F |
3.6 Singapore Chemotherapy Market Revenues & Volume Share, By Indication, 2020 & 2030F |
3.7 Singapore Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2020 & 2030F |
3.8 Singapore Chemotherapy Market Revenues & Volume Share, By End-Users, 2020 & 2030F |
4 Singapore Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Singapore Chemotherapy Market Trends |
6 Singapore Chemotherapy Market, By Types |
6.1 Singapore Chemotherapy Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Singapore Chemotherapy Market Revenues & Volume, By Drug Class, 2020-2030F |
6.1.3 Singapore Chemotherapy Market Revenues & Volume, By Alkylating Agents, 2020-2030F |
6.1.4 Singapore Chemotherapy Market Revenues & Volume, By Mitotic Inhibitors, 2020-2030F |
6.1.5 Singapore Chemotherapy Market Revenues & Volume, By Antimetabolites, 2020-2030F |
6.1.6 Singapore Chemotherapy Market Revenues & Volume, By Topoisomerase Inhibitors, 2020-2030F |
6.1.7 Singapore Chemotherapy Market Revenues & Volume, By Antitumor Antibiotic, 2020-2030F |
6.2 Singapore Chemotherapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Singapore Chemotherapy Market Revenues & Volume, By Lung Cancer, 2020-2030F |
6.2.3 Singapore Chemotherapy Market Revenues & Volume, By Breast Cancer, 2020-2030F |
6.2.4 Singapore Chemotherapy Market Revenues & Volume, By Colorectal Cancer, 2020-2030F |
6.2.5 Singapore Chemotherapy Market Revenues & Volume, By Prostate Cancer, 2020-2030F |
6.2.6 Singapore Chemotherapy Market Revenues & Volume, By Stomach Cancer, 2020-2030F |
6.2.7 Singapore Chemotherapy Market Revenues & Volume, By Lymphoma, 2020-2030F |
6.2.8 Singapore Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.2.9 Singapore Chemotherapy Market Revenues & Volume, By Ovarian Cancer, 2020-2030F |
6.3 Singapore Chemotherapy Market, By Route of Drug Administration |
6.3.1 Overview and Analysis |
6.3.2 Singapore Chemotherapy Market Revenues & Volume, By Intravenous, 2020-2030F |
6.3.3 Singapore Chemotherapy Market Revenues & Volume, By Oral, 2020-2030F |
6.3.4 Singapore Chemotherapy Market Revenues & Volume, By Subcutaneous, 2020-2030F |
6.3.5 Singapore Chemotherapy Market Revenues & Volume, By Intra-Muscular, 2020-2030F |
6.3.6 Singapore Chemotherapy Market Revenues & Volume, By Intravesicular, 2020-2030F |
6.3.7 Singapore Chemotherapy Market Revenues & Volume, By Topical, 2020-2030F |
6.3.8 Singapore Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.3.9 Singapore Chemotherapy Market Revenues & Volume, By Intraventricular/Intrathecal, 2020-2030F |
6.4 Singapore Chemotherapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Singapore Chemotherapy Market Revenues & Volume, By Specialty Centers, 2020-2030F |
6.4.3 Singapore Chemotherapy Market Revenues & Volume, By Hospitals & Clinics, 2020-2030F |
7 Singapore Chemotherapy Market Import-Export Trade Statistics |
7.1 Singapore Chemotherapy Market Export to Major Countries |
7.2 Singapore Chemotherapy Market Imports from Major Countries |
8 Singapore Chemotherapy Market Key Performance Indicators |
9 Singapore Chemotherapy Market - Opportunity Assessment |
9.1 Singapore Chemotherapy Market Opportunity Assessment, By Drug Class, 2020 & 2030F |
9.2 Singapore Chemotherapy Market Opportunity Assessment, By Indication, 2020 & 2030F |
9.3 Singapore Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2020 & 2030F |
9.4 Singapore Chemotherapy Market Opportunity Assessment, By End-Users, 2020 & 2030F |
10 Singapore Chemotherapy Market - Competitive Landscape |
10.1 Singapore Chemotherapy Market Revenue Share, By Companies, 2023 |
10.2 Singapore Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |